Antimicrobial resistance has so far cost billions of dollars in health care and lost productivity. Ottawa provides funding for barely 22% of health spending, which is way below the 50% originally promised.
Doesn’t this disengagement create a major fiscal imbalance that weakens the capacity of Quebec and the provinces to meet their own public health priorities?
